466 Combined inhibition of KRAS G12C and PD-1 boosts the therapeutic efficacy via conditioning of tumor microenvironment in pre-clinical humanized NSCLC mouse models

• Panpan Wang,
• Jingjing Wang,
• Yawen Zhang,
• Xiangnan Qiang,
• Qingyang Gu,
• Ting Ni,
• Tongxin Huo,
• Huacheng He,
• Wenting Shi

Affiliations

Panpan Wang

2WuXi AppTec, Shanghai, China

Jingjing Wang

3WuXi AppTec, Cambridge, MA, USA

Yawen Zhang

1WuXi AppTec, Suzhou, Jiangsu, China

Xiangnan Qiang

3WuXi AppTec, Cambridge, MA, USA

Qingyang Gu

1WuXi AppTec, Suzhou, Jiangsu, China

Ting Ni

1WuXi AppTec, Suzhou, Jiangsu, China

Tongxin Huo

1WuXi AppTec, Suzhou, Jiangsu, China

Huacheng He

2WuXi AppTec, Shanghai, China

Wenting Shi

1WuXi AppTec, Suzhou, Jiangsu, China